Med Ed Report briefs: January 2013

Gavin Houston
Gavin Houston

Results of a survey of about 170 CME organizations by meeting/training firm Omnipress found that over 98% deliver CME via a classroom-style setting. Of those, 54% offered programs only in a face-to-face environment, with no online offering. Less than 2% offered CME training in an online-only environment, while 44% offer a blended solution—face-to-face training with an online component.

Doctors.net.uk, which bills itself as the largest professional network of UK doctors, launched two educational quiz apps to test HCPs' medical knowledge, reports PharmaTimes. Medical Quiz Lite can be downloaded for free via iTunes, and a premium version of the app costs £1.49 and includes a free multiple choice quiz.

Healthcare meeting planner WorldEvents appointed Gavin Houston as chief executive officer for the Americas. He most recently served as the US operation's EVP.

The Physician Payment Sunshine rule was completed by CMS and has been sent to the Office of Management and Budget (OMB) for review of its economic impact on government and industry. A finalized rule must be issued 90 days after receipt of the rule by OMB, which is  February 25.
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.